Best Oncology Centers in China for International Patients
A comprehensive guide to China's top cancer hospitals, treatment approaches, costs, and how to choose the right center for your cancer care journey.
A cancer diagnosis is one of the most challenging experiences anyone can face, and the decision of where to seek treatment is among the most consequential choices you will make. China has emerged as a significant global destination for oncology care, offering world-class cancer hospitals with cutting-edge technology, internationally trained specialists, and treatment costs that are a fraction of what patients pay in the United States and Western Europe. For international patients navigating this complex landscape, understanding which hospitals lead in specific cancer types, what treatments are available, and how the costs compare is essential to making an informed decision.
China's top oncology centers have invested heavily in advanced radiation therapy platforms, robotic surgery systems, molecular diagnostics, and precision medicine capabilities. Many of these hospitals participate in global clinical trials, giving patients access to novel therapies that may not yet be available in their home countries. At the same time, China's unique integration of Traditional Chinese Medicine (TCM) with modern oncology offers supportive care pathways that can help manage treatment side effects and improve quality of life during and after cancer therapy.
This guide ranks China's ten best oncology hospitals for international patients, explains the treatment approaches available — from proton therapy to CAR-T immunotherapy to TCM integration — provides detailed cost comparisons with US and European benchmarks, and walks you through the key factors to consider when choosing an oncology center. Whether you are seeking a second opinion, exploring treatment options abroad, or planning a medical journey to China, this guide will help you navigate the landscape with clarity and confidence.
1. Cancer Care in China: A Comprehensive Overview
China's cancer care infrastructure has undergone a dramatic transformation over the past two decades. The country now operates one of the world's largest networks of specialized cancer hospitals, many affiliated with top medical universities. According to data from the National Cancer Center of China, the country diagnoses approximately 4.8 million new cancer cases annually, and this immense patient volume has given Chinese oncologists deep clinical experience across virtually every cancer type. The five-year survival rates for many cancers in China's top-tier hospitals now approach or match those of leading Western cancer centers, particularly for cancers of the stomach, liver, esophagus, and nasopharynx — areas where Chinese oncologists are globally recognized leaders.
The Chinese government has designated oncology as a national healthcare priority, resulting in sustained investment in infrastructure, research, and talent development. This includes the establishment of National Regional Cancer Centers across multiple provinces, the expansion of proton and heavy ion therapy facilities (China now operates one of the fastest-growing networks of particle therapy centers globally), and the creation of national cancer screening programs that have generated enormous datasets for epidemiological research and clinical trial recruitment. The China National Cancer Center and the Chinese Academy of Medical Sciences coordinate much of this national effort, setting treatment guidelines and quality standards that the top hospitals follow.
For international patients, the key advantages of seeking cancer care in China fall into three categories. First, access to clinical expertise: China's busiest oncology surgeons and medical oncologists treat volumes of specific cancers that few Western physicians can match — a gastric cancer surgeon at Peking University Cancer Hospital may perform several hundred gastrectomies per year. Second, access to technology and trials: Chinese cancer hospitals have invested in next-generation sequencing platforms, robotic surgery systems, and advanced radiotherapy equipment, and many participate in global multicenter clinical trials for new immunotherapies and targeted agents. Third, cost: even at China's most prestigious hospitals, cancer treatment costs are typically 50–80% lower than equivalent care in the United States, and 40–60% lower than in major European cancer centers.
That said, international patients should approach their journey with realistic expectations. English-language support varies significantly between hospitals — dedicated international departments offer excellent coordination, while general oncology wards may have limited English-speaking staff. The patient experience in a Chinese public hospital can be culturally different from what Western patients are accustomed to, with faster-paced consultations and less emphasis on the psychosocial dimensions of care. The cultural integration of family involvement in medical decision-making is also different. However, for patients who prioritize clinical expertise and affordability, and who are prepared for the cultural differences, China's best oncology centers represent an exceptional option.
5-Year
Cancer survival rates at top Chinese hospitals now approach Western benchmarks for major cancer types
50–80%
Cost savings compared to US cancer treatment at China's top oncology centers
100+
Active clinical trials at major Chinese cancer hospitals, many open to international enrollment
2. Top 10 Oncology Hospitals in China for International Patients
The following ranking is based on a combination of factors relevant to international patients: national specialty rankings from the authoritative Fudan Hospital Ranking, availability of international patient services and English-speaking staff, depth of oncology subspecialty expertise, research output and clinical trial activity, advanced technology availability, and real-world experience treating foreign patients. All ten hospitals are Grade III Level A (the highest designation in China's hospital grading system) and have dedicated international patient pathways.
1
Peking Union Medical College Hospital (PUMCH)
Beijing — Ranked #1 Hospital in China Overall
PUMCH is consistently ranked as China's number one hospital and serves as the national referral center for the most complex and difficult-to-diagnose cases. Its oncology department benefits from the hospital's extraordinary depth across all medical specialties, enabling truly multidisciplinary cancer care. PUMCH's international medical services department provides English-speaking coordinators and expedited pathways for foreign patients. The hospital is particularly strong in complex internal medicine oncology, rare tumor types, and cases requiring coordination across multiple specialties. With a comprehensive rare disease program and diagnostic capabilities that are unmatched in China, PUMCH is an excellent choice for international patients with unusual or diagnostically challenging cancers.
Peking University Cancer Hospital is one of China's most prestigious specialized cancer hospitals, with its oncology department ranked #3 nationally. As a dedicated cancer center, every resource — from surgical suites to pathology labs to clinical trial infrastructure — is optimized for oncology care. The hospital runs over 100 active clinical trials at any given time, giving patients access to cutting-edge immunotherapies and targeted agents. It is particularly renowned for gastrointestinal oncology, with Professor Ji Jiafu being an internationally recognized leader in gastric cancer surgery. The hospital's TrueBeam linear accelerator and intraoperative radiation therapy capabilities place it at the forefront of radiation oncology. English support is limited but available through the international clinic.
Shanghai — Premier Center for Hepatic and GI Oncology
Zhongshan Hospital, affiliated with Fudan University, is one of Shanghai's flagship hospitals and a national leader in liver cancer surgery and treatment. Its hepatic surgery department is ranked #2 nationally, and the hospital pioneered liver transplantation techniques in China. The oncology department provides comprehensive cancer care with particular strengths in liver, pancreatic, and gastrointestinal malignancies. The hospital features a Da Vinci robotic surgery system, hybrid operating rooms, and advanced interventional oncology capabilities. An international patient services department with English-speaking coordinators helps foreign patients navigate the care process. For international patients with liver cancer, colorectal metastases, or complex hepatobiliary oncology needs, Zhongshan Hospital offers world-class expertise.
OncologyHepatic Surgery #2Da Vinci Robotic Surgery
Ruijin Hospital is globally renowned for its hematology department, ranked #2 in China, which developed the groundbreaking arsenic trioxide plus ATRA protocol for acute promyelocytic leukemia (APL) — achieving remission rates exceeding 95%. This treatment paradigm, pioneered by Ruijin's researchers, literally transformed a once-lethal leukemia into one of the most curable forms of cancer. The hospital's oncology department covers the full spectrum of solid tumor care as well, supported by state-of-the-art diagnostic platforms including next-generation gene sequencing and flow cytometry. The international medical center provides English and French language support, and the hospital has extensive experience treating international patients, particularly from Southeast Asia, the Middle East, and Europe. For leukemia, lymphoma, and other hematologic malignancies, Ruijin is among the world's best.
Guangzhou — Historic Excellence in Breast Cancer and Solid Tumor Oncology
Founded in 1835 as the first Western medicine hospital in China, Sun Yat-sen Memorial Hospital brings nearly two centuries of clinical tradition to modern oncology care. The hospital's breast surgery department is ranked #7 nationally, and it houses the Guangdong Provincial Key Laboratory of Breast Cancer Diagnosis and Treatment. Academician Song Erwei, a leading researcher in breast cancer microenvironment and immunotherapy, heads the breast oncology program. The hospital maintains an extensive clinical trial portfolio in solid tumor oncology and offers a full range of surgical, medical, and radiation oncology services. Located in Guangzhou, the capital of Guangdong province, the hospital is a natural choice for international patients from Southeast Asia and the Chinese diaspora, with Cantonese, Mandarin, and English language support available.
Guangzhou — South China's Largest Comprehensive Cancer Care Provider
As the largest hospital in South China with 2,800 beds and an annual outpatient volume exceeding 4 million, Guangdong Provincial People's Hospital offers scale and breadth that few hospitals can match. Its oncology department is integrated with nationally ranked programs in cardiology, cardiac surgery, nephrology, and lung transplantation, enabling comprehensive care for cancer patients with significant comorbidities. The hospital's international patient department facilitates care for foreign patients, and its location in Guangzhou — a historic gateway for international trade and medical tourism — means it has more experience with foreign patients than many northern hospitals. For international patients seeking oncology care in a large, well-equipped institution with English and Cantonese language support, this hospital is a strong option.
Hangzhou — Dedicated Cancer Center with Proton Therapy in a Restorative Setting
Zhejiang Cancer Hospital is one of China's earliest specialized cancer hospitals, founded in 1963, with an oncology department ranked #10 nationally. It offers comprehensive cancer treatment including advanced radiation therapy, chemotherapy, surgical oncology, and cancer prevention programs. The hospital is known for its proton therapy capabilities, placing it among a select group of Chinese institutions with particle therapy technology. Located in Hangzhou, a city famous for its scenic West Lake and restorative natural environment, the hospital offers international patients a uniquely peaceful setting for cancer treatment and recovery. The Banshan campus is situated in a quiet, green area away from the urban center. English support is available through the international clinic.
Shenzhen — International-Standard Oncology with Hong Kong Management
A unique joint venture between the University of Hong Kong and the Shenzhen municipal government, HKU-Shenzhen Hospital operates under Hong Kong's healthcare management model — the closest thing to a Western hospital management approach in mainland China. This means patient-centered care pathways, fully bilingual (English and Chinese) clinical environments, and Western-style communication practices. The oncology department offers precision medicine programs and participates in international clinical collaborations. For international patients who want the clinical resources of a major Chinese hospital combined with the communication style and management standards of a Western institution, HKU-Shenzhen Hospital is an outstanding choice. Its location in Shenzhen, immediately adjacent to Hong Kong, provides easy access and a cosmopolitan urban environment.
Zhongnan Hospital's Oncology (Chemo-Radiotherapy) department is ranked #8 nationally, making it one of China's premier centers for combined-modality cancer treatment. The hospital's expertise in integrating chemotherapy with advanced radiation techniques — including IMRT, IGRT, and stereotactic body radiotherapy — makes it particularly valuable for patients with cancers where combined chemo-radiation is the standard of care, such as head and neck cancers, cervical cancer, esophageal cancer, and locally advanced lung cancer. The hospital also has a nationally ranked urology department (#6) that collaborates closely with oncology for genitourinary cancers. Wuhan's status as a major transportation hub in central China makes the hospital logistically accessible for international patients arriving via the city's international airport and high-speed rail network.
Oncology (Chemo-Radiotherapy) #8Urology #6Critical Care
The First Affiliated Hospital of Zhejiang University
Hangzhou — Comprehensive Oncology with World-Class Organ Transplant
The First Affiliated Hospital of Zhejiang University brings exceptional capabilities in hepatology, organ transplantation, and infectious diseases to its oncology program. Ranked #1 nationally in infectious diseases and #3 in organ transplant, the hospital offers unique expertise for cancer patients with concurrent liver disease or those requiring complex multidisciplinary care. Its oncology department provides the full spectrum of cancer treatments, supported by one of China's strongest academic medical universities. The hospital's international clinic can facilitate English-language communication and expedited appointments for foreign patients. For international patients with liver cancer, hepatitis-related malignancies, or cancers complicated by infectious comorbidities, this hospital combines top-ranked specialist expertise with Hangzhou's famously serene recovery environment.
3. Treatment Approaches: What's Available in China's Top Oncology Centers
China's leading cancer hospitals offer the full spectrum of modern oncology treatments, from established modalities like surgery and conventional chemotherapy to the most advanced targeted therapies and immunotherapies. What distinguishes China's oncology landscape is the speed at which new technologies are adopted, the scale of clinical experience, and the unique availability of integrated Traditional Chinese Medicine supportive care.
Proton and Heavy Ion Therapy
China is in the midst of a major expansion in particle therapy, with multiple proton and heavy ion therapy centers now operational in Shanghai, Beijing, and other major cities. Proton therapy delivers highly targeted radiation that spares surrounding healthy tissue — a critical advantage for tumors near sensitive structures like the brainstem, spinal cord, and optic nerves, and for pediatric cancers where minimizing radiation exposure to developing tissues is essential. The Shanghai Proton and Heavy Ion Center (SPHIC), affiliated with Fudan University, is one of the most advanced particle therapy facilities in Asia and treats international patients. Zhejiang Cancer Hospital and other centers also offer proton therapy capabilities.
The cost of proton therapy in China is substantially lower than in the United States. A full course of proton therapy in China typically costs between USD 30,000 and USD 60,000, compared to USD 100,000–200,000 in the US. While still a significant investment, this cost differential has made China an attractive destination for international patients seeking proton therapy for appropriate indications. Wait times are also generally shorter than at major proton centers in the US and Europe.
Immunotherapy and Targeted Therapy
Chinese oncology centers have embraced immunotherapy with remarkable speed. Checkpoint inhibitors (anti-PD-1, anti-PD-L1, anti-CTLA-4), CAR-T cell therapy, and bispecific antibodies are all available at major cancer hospitals, often at prices significantly lower than in Western markets. China has developed its own domestic immunotherapy drugs (including toripalimab, sintilimab, and camrelizumab) that have demonstrated efficacy comparable to international brands in rigorous clinical trials, at a fraction of the cost. For example, a cycle of anti-PD-1 immunotherapy in China may cost USD 2,000–6,000, compared to USD 10,000–15,000 in the US.
China's large population and centralized hospital system make it an ideal environment for clinical trials, and many of the world's largest oncology trials now include Chinese sites. This means international patients treated at major Chinese cancer centers may have access to novel immunotherapies and targeted agents through clinical trials — sometimes years before these drugs receive regulatory approval in their home countries. Hospitals like Peking University Cancer Hospital and Fudan-affiliated centers are particularly active in the clinical trial space.
Key advantage: China's domestic immunotherapy drugs have driven down treatment costs dramatically while maintaining strong efficacy profiles. For international patients paying out of pocket, this can make the difference between affordable care and financial catastrophe.
Traditional Chinese Medicine (TCM) Integration
One of the most distinctive aspects of cancer care in China is the integration of Traditional Chinese Medicine with conventional oncology. This is not alternative medicine replacing standard treatment — it is complementary supportive care designed to reduce chemotherapy side effects, improve appetite and energy levels, manage pain, and enhance overall quality of life during and after cancer treatment. Major oncology centers, including those affiliated with Western-medicine universities, routinely offer TCM consultations as part of comprehensive cancer care.
TCM approaches commonly used in Chinese oncology include herbal medicine formulations to support immune function and reduce treatment toxicity (such as Astragalus-based formulas for chemotherapy-related fatigue), acupuncture for chemotherapy-induced nausea, peripheral neuropathy, and cancer pain, and dietary therapy based on TCM principles to support nutritional status. Research published in peer-reviewed international journals has documented measurable benefits of certain TCM interventions for specific side effects of cancer treatment. For international patients open to integrative approaches, this dimension of Chinese cancer care can provide meaningful symptom relief and improved treatment tolerance that may not be available in purely Western oncology settings.
4. Cancer Treatment Costs: China vs US vs Europe
The cost advantage of cancer treatment in China is one of the most compelling reasons international patients consider this option. Even at China's most prestigious cancer hospitals, treatment costs are substantially lower than in Western countries, and this is true across the entire spectrum of oncology care — from initial consultation and diagnostic workup to surgery, radiation, systemic therapy, and follow-up. The savings are most dramatic for expensive treatments like immunotherapy, proton therapy, and complex surgical procedures requiring extended hospitalization.
Procedure
China (USD)
US (USD)
Europe (USD)
Oncology Consultation (Specialist)
$80 – $300
$300 – $800
$200 – $500
PET-CT Scan
$500 – $1,200
$2,500 – $5,000
$1,000 – $2,500
Radical Cancer Surgery (e.g., Gastrectomy)
$10,000 – $20,000
$40,000 – $80,000
$20,000 – $45,000
Radiation Therapy (Full IMRT Course)
$5,000 – $15,000
$25,000 – $60,000
$15,000 – $35,000
Proton Therapy (Full Course)
$30,000 – $60,000
$100,000 – $200,000
$60,000 – $120,000
Immunotherapy (per cycle, anti-PD-1)
$2,000 – $6,000
$10,000 – $15,000
$5,000 – $10,000
Chemotherapy (per cycle, standard regimen)
$1,000 – $4,000
$5,000 – $15,000
$3,000 – $8,000
💡Important: These are indicative ranges based on publicly available data and represent treatment at top-tier Chinese hospitals (Grade III Level A). Actual costs depend on the specific diagnosis, treatment complexity, hospital choice (public vs international), length of stay, and individual patient factors. Always request a detailed written quote from the hospital before committing to treatment. Prices do not include travel, accommodation, or visa costs.
Beyond the direct treatment costs, international patients should budget for travel (round-trip international flights and local transportation), accommodation (hotel or serviced apartment for the treatment duration, or a family member's stay), visa fees, interpretation services if needed, and living expenses during the treatment period. Even accounting for these ancillary costs, the total cost of a cancer treatment journey to China typically remains substantially lower than treatment in the United States, and competitive with or lower than treatment in major European centers. Our detailed cost comparison page provides further breakdowns by procedure and city.
5. How to Choose the Right Oncology Center in China
Choosing the right cancer hospital is a deeply personal decision that should be guided by your specific diagnosis, treatment goals, personal circumstances, and preferences. What is right for one patient may not be right for another. The following framework will help you evaluate your options systematically.
Match the Hospital's Strengths to Your Specific Cancer Type
Not all top hospitals excel in every cancer type. Zhongshan Hospital is a world leader in liver cancer but may not be the best choice for breast cancer. Ruijin Hospital transformed leukemia treatment globally but its strength in solid tumors, while strong, does not match its hematology prowess. Research which hospitals have nationally ranked departments for your specific diagnosis. Look at the Fudan Hospital Ranking specialty data, the hospital's research focus areas, and the volume of cases they treat in your cancer type. A surgeon who performs 300 gastrectomies per year is in a different league from one who performs 30. Our hospital profile pages include specialty rankings, research highlights, and notable doctor information to help you make this assessment.
Evaluate the International Patient Infrastructure
The presence of a dedicated international medical department can transform your experience. Hospitals like PUMCH, Zhongshan Hospital, and Ruijin have international clinics with English-speaking coordinators who handle appointment scheduling, interpretation, billing, and liaison with your home-country physician. These departments understand the specific needs of foreign patients — from visa invitation letters to insurance coordination to culturally sensitive communication. A hospital without a dedicated international patient pathway may offer excellent clinical care but the logistical and communication challenges can add significant stress. Our 'How to See a Doctor in China' guide provides detailed practical advice on navigating the system.
Consider Geographic Location and Recovery Environment
Cancer treatment often requires an extended stay — weeks for radiation therapy, months for complex chemotherapy and surgical recovery. The city where you receive treatment becomes your temporary home. Shanghai and Beijing offer the greatest concentration of top-ranked hospitals and international amenities but have higher living costs and colder winters. Hangzhou and Guangzhou provide warmer climates, more relaxed urban environments, and potentially lower accommodation costs, while still offering excellent cancer care. Hangzhou's West Lake area, in particular, has a centuries-old reputation as a restorative destination. Shenzhen's proximity to Hong Kong provides unique advantages for patients who want easy access to an international financial and logistics hub. Consider where you will feel most comfortable during what may be a physically and emotionally demanding period.
Understand Payment and Insurance Realities
Most Chinese public hospitals — including all the oncology centers listed above — operate on a pay-as-you-go or deposit-based system. International health insurance with direct billing arrangements can dramatically simplify the experience, but only a subset of Chinese hospitals accept direct billing from international insurers. Check with both your insurer and the hospital before committing. If you are paying out of pocket, you will need ready access to funds through WeChat Pay, Alipay, cash (RMB), or international credit cards (accepted at international departments). Obtain a detailed written cost estimate before treatment begins. Our cost guide and assistance service can help you navigate the financial dimensions of cancer care in China.
Plan for Continuity of Care After Returning Home
Cancer care does not end when you leave the hospital. Before choosing a center, discuss how follow-up care will be managed after you return to your home country. Will the Chinese hospital provide remote telemedicine consultations? Can they share comprehensive treatment records — including imaging files, pathology slides, surgical notes, and chemotherapy protocols — in English for your home physician? Many top Chinese oncology centers now offer structured international patient follow-up programs with scheduled video consultations and shared electronic medical records. Establishing this continuity plan before treatment begins will ensure a smooth transition and prevent gaps in your long-term cancer surveillance and care.
Frequently Asked Questions About Cancer Treatment in China
How do Chinese oncology centers compare to Western cancer hospitals in treatment quality?
China's top-tier oncology centers — particularly those ranked in the national top 10 by the Fudan Hospital Ranking — deliver treatment quality that is comparable to leading Western cancer centers for most common cancers. In certain cancer types where Chinese oncologists have uniquely high case volumes (gastric, liver, esophageal, and nasopharyngeal cancers), outcomes at China's best hospitals actually exceed Western averages. These hospitals use the same international treatment guidelines (NCCN, ESMO), the same classes of chemotherapy drugs, and the same radiation therapy technologies as their Western counterparts. The key difference is not the quality ceiling — which is high — but the consistency floor, which varies more between hospitals. This is why choosing a top-ranked hospital with an international patient program is so important.
Will I need a translator, or do Chinese oncologists speak English?
At the international departments of major hospitals, English-speaking coordinators are available and many senior oncologists — particularly those who trained or conducted research abroad — speak functional to fluent English. However, this cannot be assumed for every interaction: nurses, technicians, junior doctors, and administrative staff may not speak English. For complex discussions about treatment options, prognosis, and clinical trial participation, we recommend using the hospital's interpretation services or bringing your own medical interpreter to ensure nuanced communication. The language barrier is generally manageable at top-tier international patient departments, but it requires planning, not assumptions.
How long would I need to stay in China for cancer treatment?
The duration depends entirely on your treatment plan. A surgical procedure with recovery may require a 2–4 week stay. A full course of radiation therapy (typically 25–35 daily fractions) requires 5–7 weeks. Combination chemotherapy plus radiation can extend to 2–3 months. Complex multi-modality treatment plans with surgery, chemotherapy, and radiation delivered sequentially may require 3–6 months or longer. Some patients choose to come to China for the surgical or technical components of their treatment and complete adjuvant therapy at home. Discuss the expected timeline with your Chinese oncologist during the initial consultation and plan your visa and accommodation accordingly. Our medical visa guide provides detailed guidance on visa types and duration.
Can I access clinical trials in China as an international patient?
Yes, some clinical trials at Chinese cancer hospitals are open to international enrollment, though this varies by trial and institution. Hospitals like Peking University Cancer Hospital, which runs over 100 active trials at any time, are the most likely to have internationally accessible studies. Clinical trial participation can provide access to novel therapies at reduced or no cost. However, trial eligibility criteria, language requirements for informed consent, and the logistics of participating in a trial as a foreign national all require careful navigation. If you are interested in clinical trial participation, discuss this with the hospital's international patient department before traveling.
Is Traditional Chinese Medicine a substitute for conventional cancer treatment?
No. Traditional Chinese Medicine in Chinese oncology settings is used as complementary supportive care — not as a replacement for surgery, radiation, chemotherapy, or immunotherapy. Reputable Chinese oncology centers do not claim that TCM alone can cure cancer, and they will not encourage you to forgo evidence-based conventional treatment in favor of herbal medicine. The role of TCM is to help manage treatment side effects (nausea, fatigue, pain, appetite loss), support immune function, and improve quality of life during and after conventional cancer treatment. Patients should be transparent with both their Chinese oncologist and their TCM practitioner about all treatments they are receiving, as some herbal preparations can interact with chemotherapy drugs or affect liver function.
What should I do first if I am considering cancer treatment in China?
Start by gathering your complete medical records, including your pathology report, imaging studies (on CD/DVD with the viewer software), surgical reports if applicable, chemotherapy and radiation records, and a summary letter from your current oncologist explaining your diagnosis, treatment history, and current status. Have these documents translated into English or Chinese if they are in another language. Then, identify 2–3 hospitals from this guide that specialize in your cancer type and contact their international patient departments directly. Send your records for a preliminary review. Most hospitals will provide an initial assessment and treatment recommendation within 1–2 weeks. Use our free assistance service if you need help connecting with hospitals, understanding your options, or navigating the logistics of a cancer treatment journey to China.
Need Help Finding the Right Oncology Center in China?
Our team can help you identify the best cancer hospital for your specific diagnosis, connect you with international patient departments, and guide you through the logistics — all at no cost to you.